An experimental vaccine developed at the University of Houston can trap fentanyl in the bloodstream and keep it from reaching the brain; early human testing is now underway. Researchers call the animal results dramatic but say human data are needed before any rollout.

Biogen agreed to buy San Diego‑based RayThera for up to $1 billion, adding early‑stage immunology candidates and a lead program heading into Phase 1.

NASA selected Relativity Space to fly the Aeolus Mars climate orbiter from Cape Canaveral; the mission will map winds, dust and temperatures to sharpen models and landing forecasts.

A DOE safety milestone and Meta’s backing have accelerated Oklo’s plan for a 1.2‑GW nuclear campus at the former PORTS site in Pike County, promising jobs and reviving safety debates. Local history and HALEU supply timelines will shape the next phase.

UC San Diego’s Moores Cancer Center won a five‑year NCI core grant renewal — roughly $25M — to speed trials, hire physicians and expand infusion capacity across San Diego.

Nokia is investing $30M to expand photonics manufacturing in Allentown, promising up to 10x capacity and hundreds of local tech jobs supported by state and CHIPS funding.

Allegheny General’s Mario Lemieux Center has opened a newly renovated $19M cath lab, bringing pulsed‑field ablation and upgraded electrophysiology tools to the North Side.

The Army and Carnegie Mellon staged a robotics and autonomy forum at CMU’s new RIC this week, underscoring Pittsburgh’s bid to attract defense‑tech contracts and jobs.

A Cincinnati‑led genetics analysis of 944 children found dozens of risk variants that help predict which kids progress to chronic pancreatitis.

Chicago cybersecurity experts warn that AI chats and third‑party apps can expose private conversations. Here’s what happened and what to stop sharing now.

The FDA says ZOLL Medical’s Chelmsford facility failed to meet device quality and reporting rules. The company has fifteen business days to outline fixes or face enforcement.

Disney is working with Adobe to use Firefly Foundry so Imagineering can turn sketches into concept art and 3D prototypes as a $17B Walt Disney World plan moves forward.

Altaris will buy RTP‑based Simulations Plus for about $375M, taking the drug‑development software company private while pledging to keep its headquarters in the Triangle.